INNOVATIONS FOR LIFE

Aiming to make stem cell therapies and treatments available to the masses, Stem Cell Innovations (SCI) has been busy putting the finishing touches on its ICO launch. As the company prepares to take their token sale live, new advisors are being added to the team, tech is being tested and finalized, and the tension is building as the world waits for the collision of blockchain and stem cells to rapidly change the health care system around the globe.

Despite the ongoing research and development to support the foster the growth and prosperity of the stem cell industries, not enough is being done to convince governments and authorities of the extraordinary benefits of stem cell use and therapy. In addition to making stem cells more readily available to people through the use of the dual-blockchain platform, SCI will contribute a percentage of its take from the ICO token sale to the difficult yet important work being done to lobby the governments in places such as the United States. Working with the Food and Drug Administration, SCI plans to not only break down barriers that prevent US citizens from accessing stem cell therapies but also to educate and inform the public about how life-changing stem cells can be.

Most people only know what they have heard on the news or in biased documentary films about stem cell that focus on the risks and issues associated with stem cell research and development. SCI, however, wants to ensure that the proper information is getting to the people who need it most so they can make informed decisions about the treatments that will benefit them, and not the other way around, as is the case with current medical systems in many places.

There comes a point where you have to ask yourself, “how long are we going to continue to deny people the health care that they need to get better?” It’s a global epidemic — nearly as big as the conditions they are plagued with in the first place. Working in a controversial and often misunderstood, yet extraordinary field such as stem cell research and therapy, SCI can bridge the gap for the everyday person and provide them with real-time information, access to stem cell specialists and experts who can answer their questions, provide feedback, and guide treatments — even from across the globe.

With the ICO launch drawing ever nearer, critics will begin shooting holes in the blockchain-based platform to connect practitioners and patients who want and need access to stem cell therapies. But SCI is ready and has their tech on lockdown. They’ve considered all the options, done the homework, run the specs, and talked to the leading stem cell experts in the world — several of whom have recently joined the team as advisors.

Using proprietary algorithms, SCI’s platform will be able to find and match patients to stem cell therapies that will be effective for them, provide tools that will ensure a smooth and productive treatment process, and allow patients to gain much-needed access to specialists they wouldn’t otherwise have access to as they consider stem cell therapies for their conditions.

From SCI’s perspective, the world has waited long enough to benefit from a worldwide system that can harness the power of stem cells. But soon, that wait will be over.